Remdesivir and COVID: ACTT Trial
Andre Kumar
Share Talk
Visit
nejm.org
to learn more
July 31, 2023
7 hr
Default user image
Log in Sign Up
Channels
DiscoveryCardiology
Every Day
COVID
Every Day
Dermatology
Every Day
Endocrinology
Every DayATA 2022ENDO 2022
Gastroenterology
Every DayIBS
Hematology
Every DayIMF Patient & FamilyMiracles For MyelomaASH 2024
Hepatology
Every Day
Nephrology
Every DayASN 2024NKF SCM 22Kidney Week 2022
Neurology
GSA 2025
Oncology
Every DayGastrointestinalHER2+ @ ASCO 2025ESMO 2022
Ophthalmology
Every DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary Care
Every Day
Pulmonology
Every Day
Rheumatology
Every DayHIVACR 2024
Urology
Every Day
Speaker

Description

Remdesivir and COVID: ACTT Trial
Talk's display image
Remdesivir and COVID: ACTT Trial